1[3]Spandorfer SD, Sawin SW, Benjamin I, et al. Postoperative day 1 serum human chorionic gonadotropin level as a predictor of persistent ectopic pregnancy gfter conservative surgical management. Fertil Steril, 1997,68(6) :430 ～ 435.
2[4]Poppe WA, Vandenbussche N. Postoperative day 3 serum human chorionic gonadotropin dedine as a predictor of persistent ectopic pregnancy after linear salpingotomy. Eur J Obstet Gynecol Reprod Biol, 2001, 99(2): 249 ～ 252.
3Vassilidon N, Balmer J. Characterization of tubal and decidual leukocyte populations in ectopic pregnancy: evidance that endometrial granulated lymphocytes are absent from the tubal implantation site.Fertil Steril, 1998,69 (4) :760.
4Creinin MD, Drohn MA. Metrotrexate pharmacokinetics and effects in women receiving metrotrexate 50mg and 60mg per square meter for early abortion. Am J Obstet Gynecol,1997,177(6) :1444.
5Isaacs JD, Mcgehee RP, Cowan BD. Life threatening neutropenia following methotrexate treatment of ectopic pregnancy: a report of two cases. Obstet Gynecol, 1996,88 (4Pt2) :694.
6Horrigan TJ, Fanning J, Marcotte MP. Methotrexate pneumonitis after systemic treatment for ectopic pregnancy. Am J Obstet Gyncol,1997,176(3) :714.
7Ben-Shlomo I, Eliyahu S, Yanai N, et al. Methotrexate as a possible cause of ovarian cysts formation: experience with women treated for ectopic pregnancies. Fertil Steri], 1997,67 (4) :786.
8Perdu M, Camus E, Rozenberg P, et al. Treating ectopic pregnancy with the combination of mifepristone and methotrexate: a phase Ⅱ non - randomized study. Am J Obstet Gynecol, 1998,179 ( 3 Pt 1 ) :640.
9Zhang W,Wang L. Mifepfistone in treating ectopic pregnancy. Chin Med J (Engl) ,1999,112(4) :376.
10Korhonen J ,Stennan VH, Ylostalo P. Serum human chorionic gonadotropin dynamics during spontaneous resolution of ectopic Pregnancy. Fertil Steril,1994,61 (4) :632.
